Bharat Parenterals subsidiary gets US FDA approval

Innoxel Lifesciences, a subsidiary of Bharat Parenterals Limited, received an Establishment Inspection Report from the U.S. FDA for its Vadodara facility.

The approval enables the facility to supply pharmaceutical products including liquid injectables and oral liquids to the United States and European Union markets.